We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Plans New Submission Route for Extraordinary-Use New Drugs
Canada Plans New Submission Route for Extraordinary-Use New Drugs
May 18, 2010
Manufacturers of new drugs developed to meet health emergencies may soon have a distinct route to approval of their products in Canada. Includes the full text of Health Canada Plan For Extraordinary Use New Drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor